| Product Code: ETC10587689 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
Suriname anthra vaccine import market in 2024 saw significant growth, with top exporting countries being the Netherlands, Trinidad and Tobago, and the United States. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market, reflecting the dominance of these exporters. The compound annual growth rate (CAGR) from 2020 to 2024 was impressive at 33.11%, with a remarkable growth rate of 263.87% in 2024 alone. These statistics suggest a thriving market for anthra vaccine imports in Suriname, driven by strong demand and strategic partnerships with key exporting nations.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Anthra Vaccine Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Anthra Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname Anthra Vaccine Market - Industry Life Cycle |
3.4 Suriname Anthra Vaccine Market - Porter's Five Forces |
3.5 Suriname Anthra Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Suriname Anthra Vaccine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Suriname Anthra Vaccine Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Suriname Anthra Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of anthrax vaccination in Suriname |
4.2.2 Government initiatives to promote vaccination programs |
4.2.3 Rise in research and development activities to improve anthrax vaccines |
4.3 Market Restraints |
4.3.1 High cost associated with anthrax vaccines |
4.3.2 Limited access to healthcare facilities in remote areas of Suriname |
4.3.3 Concerns regarding the safety and efficacy of anthrax vaccines |
5 Suriname Anthra Vaccine Market Trends |
6 Suriname Anthra Vaccine Market, By Types |
6.1 Suriname Anthra Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Suriname Anthra Vaccine Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Suriname Anthra Vaccine Market Revenues & Volume, By Live Attenuated, 2021 - 2031F |
6.1.4 Suriname Anthra Vaccine Market Revenues & Volume, By Inactivated Vaccines, 2021 - 2031F |
6.1.5 Suriname Anthra Vaccine Market Revenues & Volume, By Recombinant Vaccines, 2021 - 2031F |
6.1.6 Suriname Anthra Vaccine Market Revenues & Volume, By Protein-Based Vaccines, 2021 - 2031F |
6.2 Suriname Anthra Vaccine Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Suriname Anthra Vaccine Market Revenues & Volume, By Human Immunization, 2021 - 2031F |
6.2.3 Suriname Anthra Vaccine Market Revenues & Volume, By Veterinary Use, 2021 - 2031F |
6.2.4 Suriname Anthra Vaccine Market Revenues & Volume, By Biodefense Programs, 2021 - 2031F |
6.2.5 Suriname Anthra Vaccine Market Revenues & Volume, By Military Use, 2021 - 2031F |
6.3 Suriname Anthra Vaccine Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Suriname Anthra Vaccine Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Suriname Anthra Vaccine Market Revenues & Volume, By Veterinary Clinics, 2021 - 2031F |
6.3.4 Suriname Anthra Vaccine Market Revenues & Volume, By Government Agencies, 2021 - 2031F |
6.3.5 Suriname Anthra Vaccine Market Revenues & Volume, By Research Centers, 2021 - 2031F |
7 Suriname Anthra Vaccine Market Import-Export Trade Statistics |
7.1 Suriname Anthra Vaccine Market Export to Major Countries |
7.2 Suriname Anthra Vaccine Market Imports from Major Countries |
8 Suriname Anthra Vaccine Market Key Performance Indicators |
8.1 Percentage increase in the number of individuals vaccinated against anthrax |
8.2 Research and development investment in new anthrax vaccine technologies |
8.3 Number of government-supported vaccination campaigns conducted annually |
9 Suriname Anthra Vaccine Market - Opportunity Assessment |
9.1 Suriname Anthra Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Suriname Anthra Vaccine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Suriname Anthra Vaccine Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Suriname Anthra Vaccine Market - Competitive Landscape |
10.1 Suriname Anthra Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Suriname Anthra Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here